May 26, 2026 07:00AM
May 26, 2026 07:00AM
Apr 30, 2026 07:00AM
Mar 9, 2026 07:00AM
Jan 9, 2026 08:05AM
Jan 9, 2026 08:04AM
Nov 19, 2025 06:40AM Cartesian Therapeutics (RNAC) PT Lowered to $30 at H.C. Wainwright
Nov 13, 2025 04:06PM
Nov 13, 2025 04:05PM
Nov 6, 2025 07:00AM
Oct 30, 2025 07:01AM
Oct 30, 2025 07:00AM
Aug 7, 2025 07:00AM
May 30, 2025 07:01AM Cartesian Therapeutics (RNAC) Announces First Participant Enrolled in the Phase 3 AURORA Trial of Descartes-08 in Patients with Myasthenia Gravis
May 30, 2025 07:00AM
May 13, 2025 07:00AM
May 8, 2025 07:00AM
May 2, 2025 07:05AM
Apr 8, 2025 07:01AM
Apr 8, 2025 07:00AM
Apr 2, 2025 07:05AM Cartesian Therapeutics Announces New Employment Inducement Grants
Apr 1, 2025 07:00AM
Mar 13, 2025 07:00AM
Jan 28, 2025 06:39AM
Jan 27, 2025 07:00AM
Jan 13, 2025 07:00AM
Dec 3, 2024 06:01AM
Dec 3, 2024 06:00AM Cartesian Therapeutics Announces Positive Updated Results from Phase 2b Trial of Descartes-08 in Participants with Myasthenia Gravis and Outlines Design of Planned Phase 3 Trial
Nov 21, 2024 07:00AM
Nov 7, 2024 07:00AM
Nov 5, 2024 09:00AM
Oct 15, 2024 07:03AM
Oct 15, 2024 07:00AM
Sep 13, 2024 06:44AM
Sep 9, 2024 07:03AM Cartesian Therapeutics (RNAC) Receives FDA Rare Pediatric Disease Designation for Descartes-08 for the Treatment of Juvenile Dermatomyositis
Sep 9, 2024 07:00AM
Sep 3, 2024 07:05AM
Sep 3, 2024 07:00AM
Aug 9, 2024 07:33AM
Aug 8, 2024 07:00AM
Jul 3, 2024 06:40AM
Jul 3, 2024 06:33AM Mizuho Reiterates Outperform Rating on Cartesian Therapeutics (RNAC)
Jul 2, 2024 04:07PM
Jul 2, 2024 04:05PM
Jul 2, 2024 06:32AM
Jul 2, 2024 06:31AM
Jul 2, 2024 06:30AM
Jul 2, 2024 06:30AM
May 22, 2024 07:01AM Cartesian Therapeutics (RNAC) Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Descartes-08 for the Treatment of Myasthenia Gravis
May 22, 2024 07:00AM

322,094 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All